- Home
- LVTX vs NMTC Comparison
LVTX vs NMTC Comparison
Compare LVTX & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- NMTC
- Stock Information
- Founded
- LVTX 2016
- NMTC 2009
- Country
- LVTX Netherlands
- NMTC United States
- Employees
- LVTX N/A
- NMTC N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- LVTX Health Care
- NMTC Health Care
- Exchange
- LVTX Nasdaq
- NMTC Nasdaq
- Market Cap
- LVTX 41.3M
- NMTC 36.8M
- IPO Year
- LVTX 2021
- NMTC N/A
- Fundamental
- Price
- LVTX $1.55
- NMTC $0.85
- Analyst Decision
- LVTX Hold
- NMTC Strong Buy
- Analyst Count
- LVTX 4
- NMTC 1
- Target Price
- LVTX $1.58
- NMTC $1.45
- AVG Volume (30 Days)
- LVTX 115.1K
- NMTC 351.5K
- Earning Date
- LVTX 08-13-2025
- NMTC 08-14-2025
- Dividend Yield
- LVTX N/A
- NMTC N/A
- EPS Growth
- LVTX N/A
- NMTC N/A
- EPS
- LVTX N/A
- NMTC N/A
- Revenue
- LVTX $4,990,000.00
- NMTC $6,629,051.00
- Revenue This Year
- LVTX N/A
- NMTC $156.99
- Revenue Next Year
- LVTX N/A
- NMTC $42.53
- P/E Ratio
- LVTX N/A
- NMTC N/A
- Revenue Growth
- LVTX N/A
- NMTC 69.00
- 52 Week Low
- LVTX $0.85
- NMTC $0.40
- 52 Week High
- LVTX $2.09
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- LVTX 55.80
- NMTC 59.21
- Support Level
- LVTX $1.53
- NMTC $0.71
- Resistance Level
- LVTX $1.59
- NMTC $0.77
- Average True Range (ATR)
- LVTX 0.03
- NMTC 0.06
- MACD
- LVTX -0.00
- NMTC 0.00
- Stochastic Oscillator
- LVTX 56.18
- NMTC 60.57
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.